Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 149 M137 M130 M150 M150 M 567 M Research & development ————— — Operating income 305 M356 M390 M339 M337 M 1.42 B Non-Operating Income, Total -78 M-90 M-10 M5 M19 M -76 M Interest expense, net of interest capitalized 70 M81 M85 M78 M78 M 322 M Non-Operating Income, excl. Interest Expenses -148 M-171 M-95 M-73 M-59 M -398 M Unusual income/expense ————— — Pretax income 234 M276 M398 M247 M267 M 1.19 B Equity in earnings 5 M8 M7 M7 M9 M 31 M Taxes 53 M61 M76 M50 M62 M 249 M Non-controlling/minority interest 03 M00— — After tax other income/expense ————— — Net income before discontinued operations 181 M215 M322 M200 M207 M 944 M Discontinued operations -2 M0-1 M3 M-2 M — Net income 179 M215 M321 M200 M205 M 941 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 179 M212 M321 M200 M205 M 938 M Basic earnings per share (Basic EPS) 0.630.771.180.750.77 3.47 Diluted earnings per share (Diluted EPS) 0.630.761.180.730.77 3.44 Average basic shares outstanding 283.29 M276.1 M271.09 M274.26 M265.78 M — Diluted shares outstanding 285.07 M277.77 M272.89 M275.97 M267.41 M — EBITDA 455 M511 M548 M609 M496 M 2.16 B EBIT 305 M356 M390 M339 M337 M 1.42 B Cost of revenue 2.49 B2.69 B2.7 B2.7 B2.96 B 11.05 B Other cost of goods sold 2.49 B2.69 B2.7 B2.7 B2.96 B 11.05 B Depreciation & amortization (cash flow) 150 M155 M158 M270 M159 M 742 M